Stock Information
Day One Biopharmaceuticals Inc (DAWN)
Ticker Symbol: DAWN
Exchange: NASDAQ
Sector: Biotechnology
Market Cap: $1,088.36 mil
Piotroski score: 3
PE Ratio: N/A
EPS (TTM): -1.0408
Revenue (TTM): $1.53 M
Dividend Yield: N/A%
ROE: -23.43%
Latest News
-
Day One Biopharmaceuticals: Commercial Performance With Catalysts Ahead
Fri, Feb 27, 2026 3:29 PM
-
What Analysts Are Saying About Day One Biopharmaceutical Stock
Wed, Feb 25, 2026 2:01 PM
-
Day One Biopharmaceuticals shares are trading lower after the company reported mixed Q4 financial results. Also, Needham and HC Wainwright lowered their respective price targets on the stock.
Wed, Feb 25, 2026 12:56 PM
-
Wedbush Maintains Outperform on Day One Biopharmaceutical, Raises Price Target to $30
Wed, Feb 25, 2026 9:29 AM
-
HC Wainwright & Co. Maintains Buy on Day One Biopharmaceutical, Lowers Price Target to $22
Wed, Feb 25, 2026 8:06 AM
-
Needham Maintains Buy on Day One Biopharmaceutical, Lowers Price Target to $17
Wed, Feb 25, 2026 6:32 AM
-
Day One Biopharmaceuticals, Inc. (DAWN) Q4 2025 Earnings Call Transcript
Wed, Feb 25, 2026 6:11 AM
-
Day One Biopharmaceuticals, Inc. 2025 Q4 - Results - Earnings Call Presentation
Wed, Feb 25, 2026 4:00 AM
Key Financials
Financial data not available
